DHRS9 Products

Description

3-alpha-hydroxysteroid dehydrogenase that converts 3-alpha-tetrahydroprogesterone (allopregnanolone) to dihydroxyprogesterone and 3-alpha-androstanediol to dihydroxyprogesterone. May play a role in the biosynthesis of retinoic acid from retinaldehyde, but seems to have low activity with retinoids. Can utilize both NADH and NADPH.

Bioinformatics

Entrez	10170 Human
Uniprot	NM_199204 Human Q9BPW9 Human AAH58883 Human NP_005762 Human NP_005762.2 Human NP_001135742 Human NP_001135743 Human
Product By Gene ID	10170
Alternate Names	RDHTBE EC 1.1.1.105 NADP-dependent retinol dehydrogenase/reductase EC 1.1.1 RDH-E2 EC 1.1 member 4,3-alpha-HSD RDH15 RDHL3ALPHA-HSD dehydrogenase/reductase (SDR family) member 9,3alpha-HSD

Diseases related to DHRS9

Discover more about diseases related to DHRS9.

Carcinoma
Malignant Neoplasms
Burkitt Lymphoma
Neoplasms
Lymphoma
Leukemia
Instabilities, Chromosomal
Adenoma
Malignant Neoplasm Of Kidney
Von Hippel-lindau Syndrome
Colonic Neoplasms
Malignant Tumor Of Colon
Kidney Neoplasm
Inflammatory Response
Polycystic Ovary Syndrome
Ulcer
Insulin Resistance
Leukemia, Myelocytic, Acute
Myeloid Leukemia
Nervousness

Pathways for DHRS9

View related products by pathway and learn more about each of the pathways below.

Cell Proliferation
Hair Cycle
Cell Differentiation
Neurogenesis
Regulation Of Gene Expression
Epithelial Cell Differentiation
Keratinocyte Differentiation
Viral Replication
Localization
Inflammatory Response

PTMs for DHRS9

Learn more about PTMs related to DHRS9.

Oxidation

Bioinformatics Tool for DHRS9

Discover related pathways, diseases and genes to DHRS9. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.